Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease. Maas-Bauer K, Kiote-Schmidt C, Bertz H, Apostolova P, et al. Bone Marrow Transplant 2020 Nov 17. pii: 10.1038/s41409-020-01122.

Read + Share

Amedeo Smart

Independent Medical Education

Maas-Bauer K, Kiote-Schmidt C, Bertz H, Apostolova P, et al. Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease. Bone Marrow Transplant 2020 Nov 17. pii: 10.1038/s41409-020-01122.
PMID: 33203951